Skip to main content
. 2023 Feb 27;29:100608. doi: 10.1016/j.bbih.2023.100608

Table 1.

Demographic and clinical characteristics of patients and healthy controls per CMV status (population staining A and B).

HC CMV- HC CMV+ MDD CMV- MDD CMV+ Test statistic p-value
n (%) 73 (64.6) 40 (35.4) 75 (59.1) 52 (40.9) χ2 = 0.56 0.45
female, n (%) 46 (63.0) 32 (80.0)a 37 (49.3) 42 (80.8)a χ2 = 17.94 <0.001
age (years), Md (IQR) 37 (20.88) 40.32 (26.55) 37 (19) 44.2 (15.675) χ2 = 5.63 0.13
CMV titer (U/mL), Md (IQR) 4 (1.9) 58.9 (43.85) 3.7 (2.02) 59.59 (40.83) χ2 = 170.08 <0.001
BMI, Md (IQR) 23.55 (4.97) 23.13 (4.39) 24.54 (5.03) 23.39 (4.34)a χ2 = 9.62 0.02
overweight/obese, n (%) 21 (28.8) 13 (32.5) 35 (46.7) 13 (25.0)a χ2 = 251.95 <0.001
CTQ sum score, Md (IQR) 31 (9) 30 (11.25) 33.5 (14.75) 42 (23)a χ2 = 22.37 <0.001
childhood trauma present, n (%) 25 (34.2) 11 (27.5) 38 (50.7) 31 (59.6) χ2 = 13.75 0.003
medicated (psychotrop.), n (%) 0 (0.0) 0 (0.0) 53 (94.6) 37 (92.5) 0.69

Notes. MDD Major depressive disorder; HC healthy controls; CMV cytomegalovirus; Md median; IQR interquartile range. Chi-square test or Fisher's exact test were performed for contingency tables, as well as Kruskal-Wallis tests for continuous outcomes.

a

Indicating significant differences as described in the section 3.1 Demographics.